Recent advances in pancreas organogenesis greatly improved the understanding of cell lineage from inner cell mass to fully differentiated -cells. Upon such knowledge, insulin-producing cells similar to -cell to certain extent are generated from various cell sources including embryonic stem cells (ESCs) and induced plurimotent stem (iPS) cells, although fully differentiated cells comparable to -cell are not yet available.
major pancreatectomy (Px) 11, 12 and some types of injury in rodents.
Until recently, there was a long discussion about which cells are responsible for the growth and regeneration of islets and, more fundamentally, whether formation of new islets (neogenesis) really occurs or not. However, recent lineage tracing experiments are expected to put an end to this discussion. Dor et al. generated a transgenic mouse strain in which insulin promoter drives the expression of tamoxifen-dependent Cre recombinase and, further, Cre activates a reporter gene. Thus, in this mouse, reporter gene is only expressed in insulin-expressing cells present at the pulse of tamoxifen, as well as their progeny. They have shown that all -cells at the observation time point used to be or progeny of -cells present at the tamoxifen injection, suggesting that adult pancreatic -cells are formed by self-duplication (replication) in normal life-time and even after minor (70%) Px 13 . On the other hand, as mentioned above, Xu et al.
have found Ngn3-positive cells in ductal lining of adult injured pancreas and shown that these cells can become islet cells both in situ and in vitro 8 . In addition, Bonner-Weir and her colleagues performed duct-specific lineage tracing experiments using carbonic anhydrase II (CAII) as a marker to test their hypothesis that mature duct epithelial cells are pancreatic progenitor. Their results show that formation of both new islets and newly differentiated acini from CAII-expressing ductal progenitors occurs during neonatal period 14, 15 and that substantial number of islets are genetically marked in duct ligated pancreatic lobe 14 . Acinar cell-specific lineage tracing of similar technique have been reported 16, 17 . According to these reports, acinar cells contribute to metaplastic duct formation in pancreatitis models but do not become a -cell after Px, exendin-4 treatment, duct ligation, or chemical pancreatitis. Taken together, new -cells seem to be formed in adult pancreas either through replication of pre-existing -cells or islet neogenesis from duct epithelial cells depending on circumstances, but not from acinar calls (Fig 2) . Very recently, Solar et al. expressed their negative view for islet neogenesis from the duct in their report dealing with Hnfpositive cells that appear early in pancreatogenesis and gradually restrained during gestation 18 . Therefore, neogenesis issue may need to be discussed a little longer until its settlement.
Various cell sources for -like cells
In vitro treatments can induce insulin-producing cells from wide range of cell sources.
A number of reports have indicated that insulin-producing cells similar to -cell to certain extent can be induced in various type of adult cells derived from bone marrow 19 , umbilical cord blood 20 , liver 21 , intestine 22 , and so on 4, 23 , after introduction of pancreatic lineage-related genes such as Pdx1. Protein transduction is another method to change cell fate as well as cell function. Protein transduction of Pdx1, BETA2/NeuroD and other factors are shown to enhance differentiation to -cell 24 . In addition to adult stem cells, Wei et al 25 showed that human amniotic epithelial cells can produce insulin mRNA under nicotinamide stimulation in vitro and can produce human insulin in several weeks when implanted in streptozotocin-diabetic mice. These studies indicate that various cell types can be used for generate -like cells, although these generated cells are not so mature as -cell in most cases and there remains safety concern if they are gene-engineered.
Pancreas-derived cells are other cell sources since exocrine pancreatic tissue is a waist after islet isolation for transplantation. Ramiya et al. 26 have reported that pancreatic duct epithelial cells obtained from adult non-obese diabetic (NOD) mice can continuously produce islet-like cell clusters after long term culture and that hyperglycemia can be controlled by transplantation of these clusters. Following this, similar in vitro generation of -like cells from cultured duct-like cells has been reported from several other groups (please refer to the other reviews 27, 28 . In addition, this differentiation is shown to be mediated, at least partly, through phosphatidylinositol-3 kinase-related pathway 29 .
As mentioned earlier, acinar cells are shown not to contribute to endocrine cell growth in vivo, but they are shown to generate -like cells in vitro through formation of cell cluster in suspension culture 30 . Furthermore, recent report showed that exocrine cells can be directly converted to -cells in vivo by introducing three transcription factors, Pdx1, Ngn3 and MafA 31 . In addition to duct and acinar cells, cells showing less differentiated fibroblast-like appearance can be cultured from pancreatic tissue.
Baertschiger et al. showed that these highly proliferative cells express transcription factors implicated to -cell development as well as several mesenchymal stem cell (MSC)-specific markers, yet it is not clear whether these cells can re-differentiate to -like cells 32 . Taken together, pancreatic duct-like cells, and even acinar cells, seem potential source for -like cells, although the details of these phenomena are mostly unknown and, in general, the growth of these cells is slow. In this aspect, MSC-like cells from the pancreas, with high proliferative ability, may be another candidate.
Embryonic stem cell (ESC) is an attractive cell source for any kind of cell therapies, because they proliferate almost indefinitely and has very wide differentiation potency (pluripotency). Since the establishment of ESC 33, 34 , many groups have studied -cell differentiation form ESC. In earlier attempts of Lumelsky et al. 35 and many other groups including ours 36 , insulin-producing cell clusters were generated through nestin-positive cells by step-wise procedures somewhat similar to ones for neural cell differentiation. However, these cells can hardly be regarded as -like cells after the report by Rajagopal et al. 37 , in which insulin-positive cells were shown to result mostly by insulin up-take from the culture medium. It is known that several types of insulin-producing cells other than -cell appear in certain neuronal cell, yolk sac and liver during embryonic development 38 . Therefore, insulin staining and mRNA expression in these early studies are now considered to be attributed mostly to differentiation toward neuron-like cells or extra-embryonic endoderm 39 , although our study showed insulin granules by electron microscope, mRNA expression of pancreatic genes such as glucagon and amylase as well as insulin and, further, significant decrease in blood glucose after transplantation to diabetic mice 36 . Anyway, lessons from these earlier attempts emphasize the importance of understanding developmental biology about pancreas and -cell.
Assady et al. reported generation of insulin-secreting cells from ESC after
spontaneous differentiation, although the number of such cells and insulin content in them was low 40 . However, their study clearly showed the possibility that -like cells can be generated from ESC, and subsequent studies employed strategies that closely follow the differentiation steps toward -cell during embryogenesis, namely ESC definitive endoderm, primitive gut tube, posterior foregut, pancreatic endoderm, endocrine presursor and finally islet of Langerhans. Following these multiple steps, D'Amour et al. generated cells that release C-peptide in response to multiple secretory stimuli from human ESCs, but they were only minimally responsive to glucose 41 .
Therefore, their methods still need some steps that induce final differentiation of -cells, e.g. second wave expression of Pdx1 and MafA expression. In the sasme line of study, Kroon et al. recently reported that pancreatic endoderm derived from human embryonic stem (hES) cells efficiently generates glucose-responsive endocrine cells after implantation into mice 42 . In this study, pancreatic endoderm-like tissue that contains few hormone-expressing cells was generated in vitro and then transplanted into epididymal fat pad to allow further development in vivo. Then, the graft became fully responsive to glucose 3 months after transplantation. So far, the factors that induce final -cell differentiation are unknown, but may be simply time longer than allowed for the in vitro protocols, or difficult to reproduce in vitro, such as vascularization and the interaction with adjacent tissues 43 . Several other groups also reported in vitro differentiation of -like cells from human ESCs, through definitive endoderm with distinct methods 44, 45 .
Induced pluripotent stem (iPS) cell 46 is an artificial cell type that is generated from somatic cells to mimic ESC. Human iPS cells avoid the ethical difficulties regarding the use of human embryos and tissue rejection following transplantation if they are generated from patients' own cells. The protocols used in humsn ESCs, iPS cells are also shown to differentiate into -like cells in vitro 47, 48 . ESC and iPS cells are potential and indefinite cell source for cell therapies. However, further studies are needed toward the final differentiation of -like cells as well as to establish acceptable safety until clinical usage.
Bioartificial pancreas
The original concept of BAP is to enable islet transplantation without immune suppression by protecting islets with semipermeable barrier against immune rejection (Fig 3) . BAP can be used not only allotransplantation but also xenotransplantation of the islets depending on the immuno-isolation property of the barrier.
As described above, artificial generation of -like cells are intensely investigated. If any of these studies reach the end to supply sufficient amount of -like cells of sufficient quality, transplantation of these cells, as well as human islets, will be regarded as a possible treatment for T1DM. However, one major difficulty in this approach is that the transplanted cells are exposed to the patient's inflammatory and autoimmune environment, which originally destroyed their own -cells. Therefore, even if a good source of -like cells can be identified for transplantation therapy, these cells need to be protected against these destructive influences. Therefore, BAP is expected to play an important role in future cellular therapy for T1DM.
BAP can be classified into several types, namely diffusion chamber, blood perfusion and encapsulation types (Fig. 4) . Each type has its advantages and drawbacks as described below.
In diffusion chamber type, islets are contained in the space surrounded by semipermeable membrane. Typically, islets are contained between two semipermeable membranes placed on both side of ring-like structure 49 . In addition, islets placed in hollow fibers can be regarded as a particular type of this kind. The structure of this type is rather simple and you can choose optimal membrane with desired pore size. On the other hand, islets tend to clump each other and undergo central necrosis. To place islets with some types of hydrogel such as agarose can avoid this clumping and improve BAP function 50 . Our group has developed mesh-reinforced polyvinyl alcohol (PVA) tube and bag of this type 51 . Recently, Yang et al. developed a chamber implantable to bone marrow cavity using calcium phosphate cement as immunoisolative device to enclose insulinoma/agarose microspheres 52 and reported therapeutic used of this to spontaneously diabetic cat 53 .
Blood perfusion type is similar to dialysis device. Blood is perfused in the hollow fiber and islets are placed around the fibers. The advantage of this type is high diffusive exchange rate, however this type is hardly implantable in a body and needs some anticoagulation treatment. Ikeda et al. developed BAP of this type and showed its effect in pancreatectomized pigs 54 .
Encapsulation type can be divided in to two categories, namely micro-encapsulation and macro-encapsulation. In micro-encapsulation, one or a few islets are encapsulated in hydrogel, such as alginate, like micro-beads. This type is favorable for substance exchange because of its large surface area. However, this type is hardly retrievable once they are implanted into the body, for example abdominal cavity. Most famous example of this type is DIABECELL®, a product of a bio-venture company, Living Cell In contrast to micro-encapsulation, macro-encapsulation encloses islets in a lager hydrogel that can be handled macroscopically. Therefore, macro-encapsulated islets are easy to retrieve and seemingly suitable for early use of artificially generated -like cells, because it can be retrieved if any kind of adverse events such as tumor formation. Our group developed macro-encapsulated islets using agarose-based hydrogel and showed the effect in xenotransplantation into prevascularized subcutaneous site 57, 58 . Another example of this type of BAP is PVA-macro-encapsulated islets. We developed this 
